A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.

Source:http://linkedlifedata.com/resource/pubmed/id/16729919

Download in:

View as

General Info

PMID
16729919